Show simple item record

dc.contributor.authorMiddleton, G
dc.contributor.authorBrock, K
dc.contributor.authorSavage, J
dc.contributor.authorMant, R
dc.contributor.authorSummers, Yvonne J
dc.contributor.authorConnibear, J
dc.contributor.authorShah, R
dc.contributor.authorOttensmeier, C
dc.contributor.authorShaw, P
dc.contributor.authorLee, SM
dc.contributor.authorPopat, S
dc.contributor.authorBarrie, C
dc.contributor.authorBarone, G
dc.contributor.authorBillingham, L
dc.date.accessioned2020-04-22T07:25:08Z
dc.date.available2020-04-22T07:25:08Z
dc.date.issued2020en
dc.identifier.citationMedina M, Sander L, Moncada S. Endothelial dysfunction on cerebral small vessel disease. J Neurol Sci. 2019;405:71.en
dc.identifier.pmid32199466en
dc.identifier.doi10.1016/s2213-2600(20)30033-3en
dc.identifier.urihttp://hdl.handle.net/10541/622907
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1016/s2213-2600(20)30033-3en
dc.titlePembrolizumab in patients with non-small-cell lung cancer of performance status 2 (PePS2): a single arm, phase 2 trialen
dc.typeArticleen
dc.contributor.departmentInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UKen
dc.identifier.journalLancet Respiratory Medicineen
dc.description.noteen]
refterms.dateFOA2020-04-22T09:08:47Z


Files in this item

Thumbnail
Name:
32199466.pdf
Size:
856.9Kb
Format:
PDF
Description:
From UNPAYWALL

This item appears in the following Collection(s)

Show simple item record